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Introduction
TN usually leads to paroxysms of short lasting but very
severe pain. Between the attacks the patient is usually
asymptomatic, but a constant dull background pain may
persist. Carbamazepine is currently the drug of first
choice in the treatment of TN. It is efficient in 70-80% of
patients but often associated with severe adverse effects
such as drowsiness, confusion, nausea and ataxia, which
may require discontinuation of medication. Surgical
interventions may not be suitable for all patients
and waiting for the procedure can be agonizing. There-
fore different non-invasive treatment options are
indispensable.
Aims
To investigate the efficacy of transcranial direct current
stimulation (tDCS) of the primary motor cortex on pain
and trigeminal nociceptive processing in subjects with
classical trigeminal neuralgia (TN).
Methods
Seventeen subjects with TN were recruited in the study.
Patients stimulated daily for 20 minutes over two weeks
using anodal (1mA) or sham tDCS in a randomized
cross-over design. Primary outcome variable was pain
intensity on a verbal rating scale (VRS). VRS and attack
frequency were assessed daily for one month before and
after tDCS using an individual patient diary. The impact
on trigeminal pain processing was assessed with pain-
related evoked potentials (PREP) and the nociceptive
blink reflex (nBR) following electrical stimulation on
both sides of the forehead (V1) before and after tDCS.
All patients gave written informed consent prior to
study inclusion. The study was approved by the Ethics
committee of University of Duisburg-Essen medical
faculty.
Results
Anodal tDCS reduced pain intensity more effectively
than sham stimulation after two weeks of treatment.
The attack frequency reduction was not significant.
PREP showed an increased N2 latency and decreased
peak-to-peak amplitude after anodal tDCS. No severe
adverse events were reported. Patients with concomitant
chronic background pain do not seem to benefit from
tDCS as described previously for medical therapy and
surgical intervention.
Conclusions
Daily anodal tDCS over two weeks ameliorates trigem-
inal pain in TN. It may become a valuable treatment
option for patients unresponsive to conventional medi-
cal treatment or on wait for surgical procedures. Inter-
national, multicenter, randomized controlled trials are
needed with higher patient numbers before a definite
recommendation can be proposed.
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